Intradermal influenza vaccine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/145 (2006.01) A61K 9/127 (2006.01)

Patent

CA 2684699

The invention relates to virosome-based influenza vaccines for the manufacture of medicaments that are administered intradermally in humans. The invention provides (trivalent) compositions comprising low doses of hemagglutinin (HA) antigen in a virosomal preparation that fulfill the immune response standards with respect to seroconversion rates, GMT-fold increase and protection rates, for use in vaccination set-ups.

La présente invention concerne des vaccins contre la grippe à base de virosome, destinés à la fabrication de médicaments qui sont administrés par voie intradermique à des êtres humains. L'invention concerne des compositions (trivalentes) contenant de faibles doses d'antigène d'hémagglutinine (HA) dans une préparation virosomale, qui répondent aux normes de la réponse immune en matière de taux de séroconversion, d'augmentation de la moyenne géométrique des titres (MGT) et de taux de protection, en vue de leur utilisation pour des mises au point de vaccins.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intradermal influenza vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intradermal influenza vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intradermal influenza vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1715304

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.